"Konsultacje urologiczne z zakresu urologii, urologii onkologicznej oraz urologii czynnościowej. Badania obrazowe - USG układu moczowego, USG jamy brzusznej, USG jąder z diagnostyką dopplerowską. Badania czynnościowe układu moczowego - ocena tempa przepływu moczu (uroflowmetria) Ośrodek badań klinicznych Leczenie operacyjne w prywatnych klinikach w Siedlcach oraz w Lublinie - endoskopowe prywatne/komercyjne operacje prostaty - enukleacja prostaty, przezcewkowa elektroresekcja prostaty w osłonie plazmowej TURPis. Leczenie operacyjne stulejki, krótkiego wędzidełka, usuwanie zmian skórnych narządów płciowych. Laserowe rozkruszanie kamieni w pęcherzu moczowym i nerkach. Biopsja prostaty - fuzja kognitywna. Cystoskopia."

During the past decade, Urologica Praktyka Lekarska Adam Marcheluk conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 2 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 2 clinical trials were completed. i.e. 40% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Urologica Praktyka Lekarska Adam Marcheluk" #1 sponsor was "Janssen Research & Development, LLC" with 3 trials, followed by "Bavarian Nordic" with 1 trials sponsored, "Bayer" with 1 trials sponsored, "Hinova Pharmaceuticals USA, Inc." with 1 trials sponsored and "Incyte Corporation" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Urologica Praktyka Lekarska Adam Marcheluk" #1 collaborator was "Merck Sharp & Dohme LLC" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Urologica Praktyka Lekarska Adam Marcheluk" are "Prostate Cancer Metastatic" (2 trials), "Cancer" (1 trials), "Castration-Resistant Prostatic Cancer" (1 trials), "Castration-resistant Prostate Cancer" (1 trials) and "Metastatic Castrate Sensitive Prostate Cancer" (1 trials). Many other conditions were trialed in "Urologica Praktyka Lekarska Adam Marcheluk" in a lesser frequency.

Most popular intervention types in "Urologica Praktyka Lekarska Adam Marcheluk" are "Drug" (6 trials), "Other" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Niraparib" (2 trials), "Prednisone" (2 trials), "Abiraterone Acetate" (1 trials) and "Abiraterone acetate (AA)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Urologica Praktyka Lekarska Adam Marcheluk" are 6 trials for "Male" genders and 1 trials for "All" genders.

Currently, there are NaN active trials in "Urologica Praktyka Lekarska Adam Marcheluk". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Urologica Praktyka Lekarska Adam Marcheluk, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Urologica Praktyka Lekarska Adam Marcheluk, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".